Skip to content
Search

Latest Stories

Chief medical officers want coronavirus vaccines to be offered to children aged 12 to 15

The UK's top medics on Monday (September 13) recommended that all 12 to 15-year-olds receive a first dose of Covid-19 vaccine, citing the benefit on avoiding disruption to education after a vaccination panel had said the decision was finely balanced. 

The advice from the chief medical officers (CMOs) in England, Scotland, Wales and Northern Ireland paves the way for the broad vaccination of children aged 12-15 in Britain, after the Joint Committee on Vaccination (JCVI) earlier in the month decided against making the recommendation.


The CMOs said that vaccinating children could reduce disruption to schools, and that "on balance provide sufficient extra advantage... to recommend in favour of vaccinating this group."

"(The UK CMOs) therefore recommend on public health grounds that ministers extend the offer of universal vaccination with a first dose of Pfizer-BioNTech Covid-19 vaccine to all children and young people aged 12-15 not already covered by existing JCVI advice," the CMOs said in a letter.

The government must formally indicate whether it will follow the CMOs' advice, though some ministers have previously expressed support for vaccinations for children. Vulnerable children in that age bracket were already eligible for shots.

The CMOs said second doses would not be offered to the age group until at least spring as they would wait for data to build up internationally.

Meanwhile, commenting on the announcement by the chief medical officers, Ruth Rankine, director of primary care at the NHS Confederation, said: “We are only just scratching the surface in understanding the impact that the pandemic has had on children and young people’s wellbeing, with demand for mental health services having increased significantly already across this age group.

“The need to keep one another safe and reduce disruption to education and our daily lives, as well as protect NHS services through vaccination, alongside the range of established infection control measures, are as important as ever, as is the need for clear communication in explaining the benefits of vaccination.

“We now await the detailed guidance on how this will be delivered but should not underestimate the potential impact this will have on primary care teams particularly as they also commence a Covid-19 booster programme as well as managing increasing complexity of patient need.

"The choice of whether to have the vaccine or not may be difficult for many, and as we know from previous announcements, patient questions and anxiety can end up being directed to primary care, so this will need an effective communication programme which responds to questions from parents and children but equally does not further significantly increase workload on these services.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less